血浆钠浓度的全基因组关联研究:噻嗪类暴露与否
在188,461名欧洲裔个体中开展全基因组关联研究,发现31个与血浆钠浓度相关的独立位点,垂体组织钠相关基因表达显著增加;未发现噻嗪诱导钠下降或低钠血症的全基因组显著位点,多基因评分与噻嗪使用间无基因-环境交互作用。
要点
- 31个独立位点与血浆钠浓度相关(P<5×10⁻⁸),垂体组织钠相关基因表达显著增加。
- 未发现与噻嗪诱导的钠浓度下降或低钠血症相关的全基因组显著位点。
- 血浆钠多基因评分与噻嗪使用对钠浓度无基因-环境交互作用(P=0.71)。
核心结论
- 遗传变异在调控血浆钠浓度中起重要作用,涉及垂体相关通路。
- 未发现噻嗪降钠效应或噻嗪诱导低钠血症的遗传易感性证据。
研究设计与样本
- 全基因组关联研究,纳入188,461名欧洲裔个体,分析血浆钠浓度、噻嗪诱导的钠浓度下降及噻嗪诱导的低钠血症。
- 检验血浆钠多基因评分与噻嗪暴露对钠浓度和低钠血症风险的基因-环境交互作用。
主要发现
- 荟萃分析识别出31个与血浆钠浓度独立相关的信号(P<5×10⁻⁸)。
- 组织特异性分析显示垂体组织钠相关基因表达显著增加(P=4.5×10⁻⁵)。
- 未发现噻嗪诱导钠浓度下降或噻嗪诱导低钠血症的全基因组显著位点。
- 血浆钠多基因评分每降低1个标准差与血浆钠降低0.43 mmol/L相关(95%CI 0.39-0.46)。
- 噻嗪使用与血浆钠降低0.80 mmol/L相关(95%CI 0.72-0.88),但无基因-环境交互作用(P=0.71)。
临床怎么用
- 血浆钠浓度的遗传调控涉及垂体相关通路,提示垂体在钠稳态中的作用。
- 噻嗪诱导的低钠血症未显示遗传易感性,临床决策暂不依赖基因信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
KEY POINTS: This large-scale genetic study identified 31 loci associated with plasma sodium concentrations in individuals of European ancestry. Tissue specificity analysis showed a significantly increased expression of sodium-associated genes in the pituitary gland. No genetic association signals were found for the risk of hyponatremia after thiazide exposure. BACKGROUND: Abnormal plasma sodium concentration represents an imbalance of total body water relative to electrolyte content. Hyponatremia is a common and potentially severe adverse event, and thiazide diuretics constitute a leading cause of drug-induced hyponatremia. METHODS: We conducted genome-wide association study analyses of plasma sodium concentration, thiazide-induced decrease in sodium concentration, and thiazide-induced hyponatremia in a total of 188,461 individuals of European ancestry. In addition, we tested for gene–environment interaction between a polygenic score developed for plasma sodium concentration and thiazide exposure on sodium concentration and hyponatremia risk. RESULTS: Meta-analysis yielded 31 independent associated signals at P < 5×10−8 with plasma sodium concentrations. Subsequent tissue specificity analysis showed a significantly increased expression of sodium-associated genes in pituitary tissue (P = 4.5×10−5). No genome-wide significant loci were found for thiazide-induced sodium concentration decrease or thiazide-induced hyponatremia. A polygenic score for plasma sodium concentration was associated with 0.43 (95% confidence interval, 0.39 to 0.46) mmol/L lower plasma sodium per SD decrease, and thiazide use was associated with 0.80 (95% confidence interval, 0.72 to 0.88) mmol/L lower plasma sodium, but we observed no gene–environment interaction effect (P = 0.71). CONCLUSIONS: These results underline the role of genetic variation in regulating plasma sodium concentration and highlight the importance of pathways involving the pituitary gland while finding no evidence of genetic predisposition for the plasma sodium–lowering effect of thiazides.
引用
- Andersson NW, Wu X, Geller F, et al. Genome-Wide Association Study of Plasma Sodium Concentrations with and without Exposure to Thiazide Diuretics. J Am Soc Nephrol. 2025. PMID: 39888683. doi:10.1681/ASN.0000000622
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。